This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jazz Pharma Still Making Investors Sing

Jazz passes my overall performance test however, and earns a current momentum grade A+.


Here is where valuation comes into play.

Data from Best Stocks Now App

I see a stock that is trading at 19 times forward earnings. Jazz is expected to continue to grow those earnings by about 19% per year over the next five years. That makes for a very reasonable price-to-earnings growth ratio of just 0.98.

Must Read: 5 Best Bond Funds to Guard Your Nest Egg

When I do the math, I come up with a five-year target price of $300 on the stock. Jazz is currently only trading at $152. In other words, I see a stock that has 98% upside potential.

Will Jazz ever get there? I don't know. But if Jazz can continue to execute, I'll stay along for the ride.

Stock Chart

Lastly, I see a chart that's still hitting new highs. As far as I'm concerned, all systems are still go on Jazz.

Out of 3,813 stocks in my Best Stocks Now app database, Jazz comes in fifth. It's a stock that I own at Gunderson Capital Management in my aggressive portfolios accounts.

Data from Best Stocks Now App

At the time of publication, the author held JAZZ in his managed portfolios.

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
JAZZ $152.47 -0.07%
AAPL $95.18 1.64%
FB $117.43 -0.96%
GOOG $692.36 -0.84%
TSLA $232.32 -3.92%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs